Please join Mission MSA for their next essential webinar, Autonomic Dysfunction in Multiple System Atrophy, where they’ll take a deep dive into the complex autonomic symptoms present in MSA and discuss practical, evidence-based management strategies.
Category Archives: MSA
Ambiguous Loss and Anticipatory Grief – Webinar Notes
Dr. Nicole Reidy
In early August 2025, CurePSP hosted a webinar with Dr. Nicole Reidy, a clinical social worker, on the important and under-discussed topics of ambiguous loss and anticipatory grief. While the talk was aimed at caregivers of those with PSP, CBD, and MSA (under the “CurePSP umbrella”), everyone challenged by uncertainty and ongoing loss will find this talk of interest.
Orthostatic Hypotension in MSA, LBD, and PD – Aug 2025 Webinar Recording and Notes
Mitchell Miglis, MD
On August 13, 2025, we co-hosted a webinar on orthostatic hypotension (orthostatic low blood pressure) in parkinsonian syndromes – Parkinson’s Disease, Multiple System Atrophy (MSA), and Lewy Body Dementia.
MSA-C Resources from the National Ataxia Foundation
source: National Ataxia Foundation
The National Ataxia Foundation has a webpage devoted to the cerebellar type of multiple system atrophy (MSA-C):
Small Study of GLP-1 in MSA Showed Placebo Effects
credit: Margaret Manning
In this study done in the UK, there was a 48-week open label trial where 50 patients with MSA participated — half received exenatide, a GLP-1 receptor agonist, and half did not. An “open label trial” is one in which both the participants and the researchers know if they are receiving the medication or not. (This is in contrast to a “double-blind trial.”)